TSE:BN

Brookfield Corp (BN.TO)

62.27
-1.21 (1.91%)
as of Jun 10, 2026, 8:00:01 pm Market Open.
280 watching
0
Investor Insights
star iconJun 11, 2026, 12:00 am

This summary was created by AI, based on 51 opinions in the last 12 months.

Brookfield Corp (BN-T) is widely regarded as a strong core holding among analysts, valued for its strong positioning in the alternative asset management space. Many experts highlight the company's diversified investment approach, particularly in sectors such as infrastructure and private equity, amidst rising interest rate concerns. Despite recent volatility, the stock is seen as trading at an attractive valuation, particularly with a potential upside noted against its net asset value (NAV). Analysts also emphasize the benefits of owning the parent company over its subsidiaries to capture broader income streams and management efficiency. Overall, the company's long-term growth prospects remain robust, driven by continuous capital deployment and record distributable earnings.

consensus icon
Consensus
Buy
valuation icon
Valuation
Undervalued
review icon
Similar
BAM
BUY

It's been basing since last September. Pays a decent dividend. As long as it holds $60, this won't revisit $49. Should be a core holding you hold for a long time.

TOP PICK

Unlike before, it is now tapping the public equity markets and able to own assets for much longer terms so it can expand its operating footprint and grow their franchises. There is a high level of debt across the globe in developed economies so we should start to see privatization strategies where sovereign assets are sold off. Brookfield Corp will be well positioned to participate.      Buy 8  Hold 2  Sell 1

(Analysts’ price target is $70.56)
HOLD
Good Q3 earnings last week, yet stocked dropped 7% by noon.

Private equity, private credit. Outperformer in recent years. Likes it, and its management, a lot. Lots of noise in the space, as well as headwinds on valuation. Don't worry about this move on one day, not the beginning of the end. Had a great run and, for that reason, may underperform in a general market correction.

BUY ON WEAKNESS

The parent to all the subsidiaries. Well positioned on a lot of trends like renewables, uranium exposure, infrastructure. Cashflows from subsidiaries are backed by hard assets under long-term, inflation-protected contracts. Very global. Alternative asset segment as a whole is growing. Oaktree Capital has been a nice avenue of growth.

Very well positioned. On pullbacks, add to or initiate a position.

BUY ON WEAKNESS
BAM vs. BN

Good question. The asset management piece is narrower than the entire Brookfield. It's a great, well-run company, so either one is fine. Overall, parent company might be a bit better longer term. But from time to time the asset management business will shine because of specific things going on in its universe.

As to which is better, it's a coin flip at any point in time.

BUY

Redomiciled to the US, which will eventually qualify it for inclusion in US indexes and, thus, increasing demand for the shares. Scary-looking chart merely reflects the recent stock split. Own this to get diversified exposure to all of the operating segments.

HOLD
Big drop of ~$30.

The stock hasn't actually dropped that much. Not a stock split, but there has been some corporate activity among the Brookfield names. You'll have to read the corporate information to get the details. Your platform will eventually adjust the numbers appropriately.

The reasons you held BN yesterday are the same reasons to hold it today.

DON'T BUY

Underperformance in April really showed how much torque it has to the downside (as well as to the upside). More volatile and cyclical than Canadian banks. Lots of office real estate, and she's not sure where that's going. Yield is 0.5%.

She prefers some of its underlying investments -- BEP.UN, BIP.UN. These have higher dividend yields and are safer (backed by long-term contracts).

BUY

Owned in both of his firm's equity mandates. Continues to be very constructive on the business, industry, management, and strategy. Leader in the alternative asset manager space. Scale advantaged. Fund flows to private equity are outstripping flows to publicly traded stocks and bonds. Global. Over $1T on balance sheet. Serial compounder.

HOLD

Gives you leverage to people who can see a bit further in this world and are good at picking up investments. See his Top Picks.

BUY
BN vs BEP-U

BN to hold the entire Brookfield family, and BM is at a discount than it has been for a while. BEP trades at a premium among renewables, which have been under pressure from Trump cancelling wind and other green projects. Also, Northland Power is far better than BEP, given NPI's better valuation and growth potential.

BUY

It is at an attractive price now and should be a core holding in any portfolio, perhaps 4 to 6%. It has a great track record of growth and is anticipated to grow by a 17% compound rate over the next 5 years. With carried interest that could be 25%. An investor meeting is coming up this week so we'll see what they say. It has grown by double digits for 25 years.

TOP PICK

Why own this instead of the subsidiaries? Simple. If you add up the value of all the subsidiaries, it's about 20% more than the current stock price. If you then add the value of the real estate they own, you're up to about 35% over current stock price. Likes private equity, and that's its prime business. Well managed + growing business + cheap stock = happy investor.

Expertise in 2 areas involved in data centres -- real estate and electricity generation via BEP.UN. Extremely well positioned for this investment opportunity. Yield is 0.54%.

(Analysts’ price target is $101.31)
PAST TOP PICK
(A Top Pick Aug 14/24, Up 43%)

A core holding, though would wait for a pullback to add more. The underlying business is private equity. Given potential changes in 401K plans in the US, there will be more demand for private equity. Large players like this are well-positioned. Has seen strong earnings growth the past year and multiples expansion. This is one of the best compounders.

BUY
Trevor Rose’s Insights - Trevor’s most-liked answers from 5i Research

BN has been consistently near the top of our growth favourites and we consider it a solid 'buy and forget' type of stock. EPS of 88c missed estimates of 90c; revenue of $18.08B beat estimates of $10.13B. Net EPS did fall year over year. A 3 for 2 stock split is planned for October. Deployable capital is a record $177B. Asset management had a 16% increase in fee-related earnings. Distributable earnings rose 13% year over year. BN sold $55B in assets. All-in, as usual, there was lots to digest. But the underlying trend of growth in cash flow continues strongly, and we remain fully comfortable here. 
Unlock Premium - Try 5i Free   

Showing 31 to 45 of 175 entries